Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Comment by mercedesmanon Feb 16, 2024 9:11am
135 Views
Post# 35883827

RE:RE:RE:RE:RE:Bloom Burton update $0.80 tp

RE:RE:RE:RE:RE:Bloom Burton update $0.80 tp

That's what is most amazing to me. 


the Target Price is basically a double from here with nothing factored in for future Kinlytic royalties which are expected to be $15m to $25m USD annually a few years after launch !

Imagine what the discounted value of that very high margin stream of cash is worth in Market Cap ? 

10X at least but to be conservative discount that by 1/2 in recognition of a 5 year wait and some execution  risk ?

warning, Real back of envelope math:

Say $20M USD annually = 
$26 M CAD
$260 M ( at a 10X multiple)
discounted to $130M ( by 1/2 for time value of money and execution risk)

Todays MC $58M
Target $116M ( excluding K)
Target including discounted K $246M ($116+130)
= a 4 bagger or $1.60/share 
increasing every year as they inch closer to realizing the stream from K  ( ie as the project is derisked ) 

Seems like a no brainer to me !?!? 

MM 
 

<< Previous
Bullboard Posts
Next >>